Literature DB >> 811183

Prolonged retention of glutaraldehyde-treated skin allografts and xenografts: immunological and histological studies.

I Schechter.   

Abstract

Glutaraldehyde (GA)-treated skin allografts and xenografts (from mice, rats and guinea-pigs) behave in the same way as judged from retention time, gross inspection, microscopic examination, and assays for graft antigenicity. The GA-treated grafts are retained for long periods of time (an increase by more than 6-fold as compared to untreated grafts), they are tightly bound to the recipient, they are initially soft but become progressively stiffer with minimal shrinkage in size, and remain free from infection. The histology shows that the grafts are nonviable and fixed by the GA, they are avascularized but the general structure of the skin (epidermis, adnexa and dermis) is preserved for about 3 months. The antigenicity of the GA-treated grafts is very poor, actually it is undetectable. They do not elicit the formation of cytotoxic antibodies, and animals sensitized by untreated allografts retain the GA-treated allografts similarly to normal unsensitized recipients. The lack of transplantation immunity is also indicated by the fact that GA-treated isografts behave and are rejected similarly to GA-treated allografts and xenografts. Microscopic examination suggests that the mechanism of rejection of GA-treated grafts is similar to that operating in the rejection of an inert foreign body. The marked prlongation in the retention of Ga-treated skin grafts and their properties justify investigations on the applicability of these grafts in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811183      PMCID: PMC1343964          DOI: 10.1097/00000658-197512000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

1.  APPLICATIONS OF ISO-IMMUNE CYTOLYSIS USING RADIOLABELLED TARGET CELLS.

Authors:  A R SANDERSON
Journal:  Nature       Date:  1964-10-17       Impact factor: 49.962

2.  FORMALIZED SKIN SUBSTITUTE FOR GRAFTING BURNS: A PRELIMINARY REPORT.

Authors:  R A PARRISH; J K TIPPENS; M M PULLIAM; W H MORETZ
Journal:  Am Surg       Date:  1964-11       Impact factor: 0.688

3.  THE ACCEPTANCE AND EVOLUTION OF DERMAL HOMOGRAFTS FREED OF VIABLE CELLS.

Authors:  H C GRILLO; C F MCKHANN
Journal:  Transplantation       Date:  1964-01       Impact factor: 4.939

4.  Mechanism for the prolonged survival of glutaraldehyde-treated skin allografts.

Authors:  H M Im; R L Simmons
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

5.  Classification of inbred rat strains for Ag-B histocompatibility antigens.

Authors:  J Palm
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

6.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

7.  Prolonged survival of glutaraldehyde-treated skin homografts.

Authors:  I Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

8.  Quantitative assessment of cellular and humoral responses to skin and tumor allografts.

Authors:  T G Canty; J R Wunderlich
Journal:  Transplantation       Date:  1971-02       Impact factor: 4.939

9.  Comparative studies on fresh and preserved skin: fundamental biologic differences in behavior as grafts.

Authors:  W M Abbott; A M Pappas
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

10.  Glutaraldehyde as a protein cross-linkage reagent.

Authors:  F M Richards; J R Knowles
Journal:  J Mol Biol       Date:  1968-10-14       Impact factor: 5.469

View more
  8 in total

1.  Prolonged survival of GalT-KO swine skin on baboons.

Authors:  Joshua Weiner; Kazuhiko Yamada; Yoshinori Ishikawa; Shannon Moran; Justin Etter; Akira Shimizu; Rex Neal Smith; David H Sachs
Journal:  Xenotransplantation       Date:  2010 Mar-Apr       Impact factor: 3.907

2.  Studies of the modified venous allograft.

Authors:  L J Perloff; D T Rowlands; C F Barker
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

3.  Lack of cross-sensitization between α-1,3-galactosyltransferase knockout porcine and allogeneic skin grafts permits serial grafting.

Authors:  Alexander Albritton; David A Leonard; Angelo Leto Barone; Josh Keegan; Christopher Mallard; David H Sachs; Josef M Kurtz; Curtis L Cetrulo
Journal:  Transplantation       Date:  2014-06-27       Impact factor: 4.939

4.  Aldehyde-treated porcine skin versus biobrane as biosynthetic skin substitutes for excised burn wounds: case series and review of the literature.

Authors:  H A El-Khatib; A Hammouda; A Al-Ghol; B Habib
Journal:  Ann Burns Fire Disasters       Date:  2007-06-30

5.  Acute aortic stenosis of a porcine valve heterograft apparently caused by graft rejection: case report with discussion of immune mediated host response.

Authors:  W M Talbert; P Wright
Journal:  Tex Heart Inst J       Date:  1982-06

6.  Development of tissue bank.

Authors:  R P Narayan
Journal:  Indian J Plast Surg       Date:  2012-05

Review 7.  Porcine Xenograft and Epidermal Fully Synthetic Skin Substitutes in the Treatment of Partial-Thickness Burns: A Literature Review.

Authors:  Herbert L Haller; Sigrid E Blome-Eberwein; Ludwik K Branski; Joshua S Carson; Roselle E Crombie; William L Hickerson; Lars Peter Kamolz; Booker T King; Sebastian P Nischwitz; Daniel Popp; Jeffrey W Shupp; Steven E Wolf
Journal:  Medicina (Kaunas)       Date:  2021-04-30       Impact factor: 2.430

8.  The Use of EZ Derm® in Partial-Thickness Burns: An Institutional Review of 157 Patients.

Authors:  Jared Troy; Rachel Karlnoski; Katheryne Downes; Kimberly S Brown; C Wayne Cruse; David J Smith; Wyatt G Payne
Journal:  Eplasty       Date:  2013-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.